Publications by authors named "A Bogte"

Article Synopsis
  • The study highlights the slow implementation of cancer treatment guidelines in the Netherlands, specifically for pancreatic cancer, aiming to improve survival rates through better adherence to best practices.
  • It involved a multicenter trial with 5887 patients, comparing enhanced treatment strategies against usual care from May 2018 to July 2020.
  • Results showed that one-year survival rates were similar between both groups (24% vs 23%) and there wasn't a significant increase in adherence to the recommended treatment practices post-implementation.
View Article and Find Full Text PDF

Simethicone is useful as premedication for upper endoscopy because of its antifoaming effects. We aimed to evaluate the effect of timing of simethicone administration on mucosal visibility. In this multicenter, randomized, endoscopist-blinded study, patients scheduled for upper endoscopy were randomized to receive 40 mg simethicone at the following time points prior to the procedure: 20 to 30 minutes (early group), 0 to 10 minutes (late group) or 20 mg simethicone at both time points (split-dose group).

View Article and Find Full Text PDF

Background: Selective cannulation and stenting of complex, tight, and/or angulated biliary strictures under endoscopic retrograde cholangiopancreaticography (ERCP) can be challenging. Digital single-operator cholangioscopy (SOC) may facilitate guidewire advancement through the stricture with endoscopic visual guidance. We aimed to describe a case series on clinical outcomes of this technique for selective cannulation, when used after failed conventional ERCP attempts.

View Article and Find Full Text PDF

Background & Aims: The combination of endoscopic resection and radiofrequency ablation is the treatment of choice for eradication of Barrett's esophagus (BE) with dysplasia and/or early cancer. Currently, there are no evidence-based recommendations on how to survey patients after successful treatment, and most patients undergo frequent follow-up endoscopies. We aimed to develop and externally validate a prediction model for visible dysplastic recurrence, which can be used to personalize surveillance after treatment.

View Article and Find Full Text PDF